MAURA TARDIF: Open Payments
NPI 1528216371 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,372 in 83 payments from 21 companies in 2025. Trend: 2023 $1,892 · 2024 $1,563 · 2025 $1,372
Food & beverage: $1,372
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $351 |
| PFIZER INC. | 10 | $155 |
| GlaxoSmithKline, LLC. | 6 | $110 |
| Novo Nordisk Inc | 6 | $106 |
| Vanda Pharmaceuticals Inc. | 4 | $89 |
| Lilly USA, LLC | 4 | $77 |
| Amneal Pharmaceuticals LLC | 4 | $74 |
| Axsome Therapeutics, Inc. | 4 | $70 |
| Dexcom, Inc. | 2 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
Products named: NURTEC ODT, UBRELVY, QULIPTA, FANAPT, UNITHROID, Rybelsus, VRAYLAR, JARDIANCE.
Industry payments across AZ — which companies pay providers there.
